Effects of ID-HWS1000 on the Perception of Bowel Activity and Microbiome in Subjects with Functional Constipation: A Randomized, Double-Blind Placebo-Controlled Study

被引:16
|
作者
Kim, Min Cheol [1 ]
Lee, Sunghee [2 ]
Park, Jin Kyung [1 ]
Park, Jongmi [1 ]
Lee, Donghun [2 ]
Park, Jaewan [2 ]
Kim, Byung-Yong [3 ]
Cho, Min Seok [3 ]
Kim, Tae-Yoon [2 ]
Park, Ha Young [1 ]
Park, Ju Hyun [4 ,5 ]
Bok, Min Kyung [4 ,5 ]
Lim, Hyunjung [4 ,5 ]
机构
[1] ILDONG Pharmaceut Co Ltd, Hwaseong, South Korea
[2] ILDONG Pharmaceut Co Ltd, Res Lab, Hwaseong, South Korea
[3] ChunLab Inc, Microbiome Res Ctr, Seoul, South Korea
[4] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea
[5] Kyung Hee Univ, Res Inst Med Nutr, Yongin, South Korea
关键词
bowel movements; functional constipation; gut microbiome; prebiotics; probiotics; CHRONIC IDIOPATHIC CONSTIPATION; GUT MICROBIOME; PROBIOTICS; PREBIOTICS; SYMPTOMS; SEARCH;
D O I
10.1089/jmf.2020.4746
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
During constipation, indigestible foods, such as probiotics, prebiotics, and dietary fiber, may improve the bowel environment and activity. In this randomized, double-blind, and placebo-controlled study, the effects of ID-HWS1000, composed of Lactobacillus and Bifidobacterium species, xylooligosaccharide, and dietary fiber, were evaluated to determine whether it improves the perception of bowel activity or cause changes in the gut microbiome. Thirty Korean adults with "functional constipation" according to the Rome III criteria were randomly assigned to the following groups: 20 in the ID-HWS1000 group and 10 in the placebo group. ID-HWS1000 or the placebo was consumed by the participants for 4 weeks. To assess the changes in the perception of bowel activity, clinical data and gut microbiome analyses were conducted before and after the experiment. There were significant differences between the groups in the response to 9 of the 12 survey questions (the number and duration of bowel movements, amount of feces, number of irritant bowel movements, number of times bowel movements felt incomplete, shape of the feces, amount of gas in the gut, discomfort after defecation, and discomfort owing to constipation) (P < .05). There was a decrease in the proportion of Firmicutes (Ruminococcaceae and Lachnospiraceae) and an increase in Bacteroidetes (Bacteroidaceae) (P < .05). Moreover, ID-HWS1000 directly improved the discomfort associated with bowel movements, decreased the proportion of Lachnospiraceae, and increased the proportion of Bacteroidaceae. These results confirmed that ID-HWS1000 improves the perception of bowel activity and exerts positive changes in individuals with functional constipation.
引用
收藏
页码:883 / 893
页数:11
相关论文
共 50 条
  • [41] Effect of the probiotic strain, Lactiplantibacillus plantarum P9, on chronic constipation: A randomized, double-blind, placebo-controlled study
    Ma, Teng
    Yang, Ni
    Xie, Yong
    Li, Yingmeng
    Xiao, Qiuping
    Li, Qiong
    Jin, Hao
    Zheng, Longjin
    Sun, Zhihong
    Zuo, Kexuan
    Kwok, Lai-Yu
    Zhang, Heping
    Lu, Nonghua
    Liu, Wenjun
    PHARMACOLOGICAL RESEARCH, 2023, 191
  • [42] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [43] Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
    Ratna Sudha Madempudi
    Jayanthi Neelamraju
    Jayesh J. Ahire
    Sandeep K. Gupta
    Vineet K. Shukla
    Probiotics and Antimicrobial Proteins, 2020, 12 : 335 - 342
  • [44] Efficacy and safety of vibrating capsule for functional constipation (VICONS): A randomised, double-blind, placebo-controlled, multicenter trial
    Zhu, Jia-Hui
    Qian, Yang-Yang
    Pan, Jun
    He, Chen
    Lan, Yu
    Chen, Wei-Na
    Wang, Bang-Mao
    Zhao, Wei
    Li, Jing-Nan
    Li, Xiao-Qing
    Lv, Bin
    Fan, Yi-Hong
    Zuo, Xiu-Li
    Li, Zhen
    Zou, Duo-Wu
    Li, Zhao-Shen
    Liao, Zhuan
    ECLINICALMEDICINE, 2022, 47
  • [45] A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome Effect on Quality of Life
    Choi, Chang Hwan
    Jo, Sun Young
    Park, Hyo Jin
    Chang, Sae Kyung
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (08) : 679 - 683
  • [46] Randomized clinical trial: rikkunshito in the treatment of functional dyspepsiaa multicenter, double-blind, randomized, placebo-controlled study
    Suzuki, H.
    Matsuzaki, J.
    Fukushima, Y.
    Suzaki, F.
    Kasugai, K.
    Nishizawa, T.
    Naito, Y.
    Hayakawa, T.
    Kamiya, T.
    Andoh, T.
    Yoshida, H.
    Tokura, Y.
    Nagata, H.
    Kobayakawa, M.
    Mori, M.
    Kato, K.
    Hosoda, H.
    Takebayashi, T.
    Miura, S.
    Uemura, N.
    Joh, T.
    Hibi, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07) : 950 - 961
  • [47] A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
    Masand, Prakash S.
    Pae, Chi-Un
    Krulewicz, Stan
    Peindl, Kathleen
    Mannelli, Paolo
    Varia, Indu M.
    Patkar, Ashwin A.
    PSYCHOSOMATICS, 2009, 50 (01) : 78 - 86
  • [48] Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta- analysis of randomized, double-blind, placebo-controlled trials
    Zhang, Wen Xue
    Shi, Lu Bo
    Zhou, Min Si
    Wu, Jing
    Shi, Hai Yun
    JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 72 (09)
  • [49] Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial
    Xiao, Ying Lian
    Dai, Ning
    He, Shui Xiang
    Tian, De An
    Liu, Si De
    Tian, Zi Bin
    Wang, Xiao Yan
    Li, Yan Qing
    Hou, Xiao Hua
    Fang, Xiu Cai
    Wen, Zhi Li
    Zeng, Wei Zheng
    Xu, Hong
    Sun, Ming Jun
    Liu, Yu Lan
    Wu, Yong Dong
    Shen, Xi Zhong
    Liu, Xiao Wei
    Liu, De Liang
    Chen, Min Hu
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (11) : 622 - 629
  • [50] Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Oh, Joo Hyun
    Jang, Yeon Sil
    Kang, Danbee
    Kim, Hong Seog
    Kim, Eui-Joong
    Park, So-Young
    Kim, Cheol-Hyun
    Min, Yang Won
    Chang, Dong Kyung
    GUT AND LIVER, 2023, 17 (01) : 100 - 107